Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by GrahamBon Nov 13, 2023 12:14pm
108 Views
Post# 35732142

RE:RE:Sales update soon?

RE:RE:Sales update soon?
GrahamB wrote:
GrahamB wrote:
Touching base, as I understand, we will be receiving financials soon, for the third quarter, and there’s only about a month left in the fourth quarter.

I have not heard much news at all about sales, which I thought odd, as they did a press release with single sales in the last year-but its crickets

Sales are what I am waiting for before making an investment. There needs to be a demand for the product, that matches the enthusiasm posted on this board, and that I have read and seen on the YouTube videos.

To date, the sales have been negligible, or in 2021, zero.
 
There was talk about a flood of sales, but the most recent investor call transcript seemed to walk that back. Just for review and for context when the financials come out, here we are to date.
 
 
For the record ie. from Sedar:
 
Total revenue for year ending Dec. 31, 2018  = $60,177
Total revenue for year ending Dec. 31, 2019  = $81,023
Total revenue for year ending Dec. 31, 2020  = $36,017
 
Total revenue for year ending Dec. 31, 2021  = $Nil
Total revenue for year ending Dec. 31, 2022 68,167

We will see soon enough.
Every quarter I have heard, next quarter-for 2 years+
all imo
 

Comment by jopatcloon Nov 13, 2023 10:13am
5 Views 
Post# 35731782

RE:Sales update soon?

"Touching base,shake..shake..game vultures FUD"


My posts lists the factual, verified sales. Full stop.
So, yes FUD=Facts Uncover Deceipt 

 


Comment by jopatcloon Nov 13, 2023 10:41am
23 Views 
Post# 35731881

RE:RE:Sales update soon?

Facts yes,
Completion of VMS+ 4.0Granham
Again, and lastly, verifiable facts of what is actually happening, Importntly sales(or almost lack therof here) 
Not stories of what will be
We have been down that road of what will happen for years
Show me the money
Show me an update has been implemented AND being demanded by cardiologists. GE has been developing thier own tech, as have others.
Tick tock
See ya
<< Previous
Bullboard Posts
Next >>